feed,title,long_url,short_url
MedRxiv,Analysis of severe illness after post-vaccination COVID-19 breakthrough among adults with and without HIV in the United States,https://medrxiv.org/cgi/content/short/2022.04.15.22273913v1?rss=1,https://bit.ly/3ElDwCf
MedRxiv,COVID-19 relevant genetic variants confirmed in an admixed population,https://medrxiv.org/cgi/content/short/2022.04.15.22273925v1?rss=1,https://bit.ly/3JLYAD9
MedRxiv,"Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (CovishieldTM) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021",https://medrxiv.org/cgi/content/short/2022.04.15.22273859v1?rss=1,https://bit.ly/3Emf2Jp
MedRxiv,Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome,https://medrxiv.org/cgi/content/short/2022.04.12.22273589v1?rss=1,https://bit.ly/3uNK7SR
MedRxiv,Dose-response modelling of endemic coronavirus and SARS-CoV-2: human challenge trials reveal the individual variation in susceptibility,https://medrxiv.org/cgi/content/short/2022.04.07.22273549v1?rss=1,https://bit.ly/3uNhCEX
MedRxiv,Effectiveness of COVID-19 mRNA vaccine booster dose relative to primary series during a period of Omicron circulation,https://medrxiv.org/cgi/content/short/2022.04.15.22273915v1?rss=1,https://bit.ly/3M6mOJS
